76 related articles for article (PubMed ID: 24831605)
1. Recovery of ovary function impaired by chemotherapy using Chinese herbal medicine in a rat model.
Xia T; Fu Y; Gao H; Zhao Z; Zhao L; Han B
Syst Biol Reprod Med; 2014 Oct; 60(5):293-303. PubMed ID: 24831605
[TBL] [Abstract][Full Text] [Related]
2. Study of Luan-Pao-Prescription on ovarian dysfunction in rats.
Jiang B; Sun K; Li M; Wang Y; Zhuang L; Zhang L; Wang Y; Liu X; Wu W; Guan S; Yang M; Li Y; Yu J; Dean-Guo
J Ethnopharmacol; 2012 Jun; 141(2):653-8. PubMed ID: 21933702
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic transplantation of cryopreserved mouse ovaries and gonadotrophin releasing hormone analogues in the restoration of function following chemotherapy-induced ovarian damage.
Li Q; Szatmary P; Liu Y; Ding Z; Zhou J; Sun Y; Luo F; Wang Y; Zhu J
PLoS One; 2015; 10(3):e0120736. PubMed ID: 25811681
[TBL] [Abstract][Full Text] [Related]
4. [Ovarian function reconstruction by orthotopic transplantation of novel vitrification cryopreserved ovaries in chemotherapy-induced ovary damage rat model].
Li Q; Chen Y; Yang L; Sun Y; Wang Y; Zhu J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1116-21. PubMed ID: 24279027
[TBL] [Abstract][Full Text] [Related]
5. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
Blumenfeld Z
Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
[TBL] [Abstract][Full Text] [Related]
6. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
[TBL] [Abstract][Full Text] [Related]
7. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
8. [Study of the prevention of chemotherapy-induced ovarian damage by gonadotropin-releasing hormone agonist in rat model].
Yuan GW; Shen K; Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):666-9. PubMed ID: 16277895
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients.
Zhu HL; Wang Y; Li XP; Wang CH; Wang Y; Cui H; Wang JL; Wei LH
Chin Med J (Engl); 2013 Feb; 126(4):688-91. PubMed ID: 23422190
[TBL] [Abstract][Full Text] [Related]
10. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
[TBL] [Abstract][Full Text] [Related]
12. Prevention of gonadal damage during cytotoxic therapy.
Blumenfeld Z; Haim N
Ann Med; 1997 Jun; 29(3):199-206. PubMed ID: 9240625
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Chinese herbal medicine mixture on a rat model of hypercholesterolemic erectile dysfunction.
Bakircioglu ME; Hsu K; El-Sakka A; Sievert KD; Lin CS; Lue TF
J Urol; 2000 Nov; 164(5):1798-801. PubMed ID: 11025772
[TBL] [Abstract][Full Text] [Related]
14. [Effect on transforming growth factor-beta1 of glucocorticoid-induced avascular necrosis of femoral head in rats by treatment of activating blood circulation of Chinese herbal medicine].
Qi ZX; Kang JD; Li SQ
Zhongguo Gu Shang; 2009 Aug; 22(8):596-8. PubMed ID: 19753978
[TBL] [Abstract][Full Text] [Related]
15. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
Blumenfeld Z
Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
[TBL] [Abstract][Full Text] [Related]
16. GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
Matsuo G; Ushijima K; Shinagawa A; Takahashi S; Fujiyoshi N; Takemoto S; Terada A; Fukui A; Kamura T
Kurume Med J; 2007; 54(1-2):25-9. PubMed ID: 18332593
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
[TBL] [Abstract][Full Text] [Related]
19. Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty.
Kilic S; Pinarli F; Ozogul C; Tasdemir N; Naz Sarac G; Delibasi T
Gynecol Endocrinol; 2014 Feb; 30(2):135-40. PubMed ID: 24308768
[TBL] [Abstract][Full Text] [Related]
20. [Protective effect of zuogui pill on ovarian autoimmune injury].
Zhu L; Luo SP; Xu LM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Oct; 25(10):920-4. PubMed ID: 16313118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
